Related references
Note: Only part of the references are listed.Juvenile idiopathic arthritis-associated uveitis in the era of biological therapy: how the disease changed in more than 20 years of observation in a tertiary referral center in Rome (Italy)
E. Del Giudice et al.
INTERNATIONAL OPHTHALMOLOGY (2022)
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia
David C. Rees et al.
BLOOD (2022)
Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions
Benedetta Guidi et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2022)
Management Strategies of Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis: Current Perspectives
Maria Pia Paroli et al.
CLINICAL OPHTHALMOLOGY (2022)
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases
Francesca Della Casa et al.
FRONTIERS IN MEDICINE (2022)
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
Carla Gaggiano et al.
FRONTIERS IN MEDICINE (2022)
IL-1 beta blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based review
Alper Soylu et al.
RHEUMATOLOGY INTERNATIONAL (2021)
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment
Giuseppe Lopalco et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2021)
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
Giulio Cavalli et al.
AUTOIMMUNITY REVIEWS (2021)
Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis
Farzana Bhuyan et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
Hana Malcova et al.
FRONTIERS IN PHARMACOLOGY (2021)
Distinguishing Blau Syndrome from Systemic Sarcoidosis
Katherine P. Kaufman et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2021)
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment
Benzeeta Pinto et al.
CLINICAL RHEUMATOLOGY (2021)
Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis
Luciana Brandao Paim et al.
INDIAN JOURNAL OF PEDIATRICS (2021)
Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature
Paola Borgia et al.
FRONTIERS IN MEDICINE (2021)
Off-label medication use in rare pediatric diseases in the United States
Albert Fung et al.
INTRACTABLE & RARE DISEASES RESEARCH (2021)
Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey
N. Ipek Kirmizi et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2021)
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behcet's Disease
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Unicentric Castleman Disease Mimicking an Autoinflammatory Disorder: A Diagnostic Challenge in a Pediatric Patient With Recurrent Fever
Rabia Miray Kisla Ekinci et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2020)
Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population
Karen M. Chisholm et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry
Ariane Klein et al.
RHEUMATOLOGY (2020)
New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation
Jasmin B. Kuemmerle-Deschner et al.
RHEUMATOLOGY (2020)
Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature
Aysenur Pac Kisaarslan et al.
ARCHIVES OF RHEUMATOLOGY (2020)
Failure of anti Interleukin-1β monoclonal antibody in the treatment of recurrent pericarditis in two children
Sara Signa et al.
PEDIATRIC RHEUMATOLOGY (2020)
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
Riccardo Papa et al.
PEDIATRIC RHEUMATOLOGY (2020)
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)
Leonardo Oliveira Mendonca et al.
PEDIATRIC RHEUMATOLOGY (2020)
Persistent Tenosynovitis, Steroid Dependency and a Hyperpigmented Scaly Macular Rash in a Child With Juvenile Idiopathic Arthritis
Eleni Maria Papatesta et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach
Peter A. Nigrovic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2019)
Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study
Jenna Sopfe et al.
PEDIATRIC BLOOD & CANCER (2019)
Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab
Serdar Epcacan et al.
CARDIOLOGY IN THE YOUNG (2019)
Refractory macrophage activation syndrome in the setting of adult-onset Still disease with hemophagocytic lymphohistiocytosis detected on skin biopsy treated with canakinumab and tacrolimus
Bahir Chamseddin et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
Interleukin-1beta Inhibition Attenuates Vasculitis in a Mouse Model of Kawasaki Disease
Yoshiaki Hashimoto et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2019)
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases
Nienke M. Ter Haar et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Complexity in unclassified auto-inflammatory disease: a case report illustrating the potential for disease arising from the allelic burden of multiple variants
Lori B. Tucker et al.
PEDIATRIC RHEUMATOLOGY (2019)
Is fibrodysplasia ossificans progressiva an interleukin-1 driven auto-inflammatory syndrome?
Ruby Haviv et al.
PEDIATRIC RHEUMATOLOGY (2019)
IL-1 BLOCKADE IN PEDIATRIC RECURRENT PERICARDITIS: A MULTICENTRIC RETROSPECTIVE STUDY ON THE ITALIAN COHORT
Roberta Caorsi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Deficiency of Interleukin-1 Receptor Antagonist: A Case with Late Onset Severe Inflammatory Arthritis, Nail Psoriasis with Onychomycosis and Well Responsive to Adalimumab Therapy
Necil Kutukculer et al.
CASE REPORTS IN IMMUNOLOGY (2019)
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
Jurgen Sota et al.
CLINICAL RHEUMATOLOGY (2018)
What is new in paediatric uveitis?
Kara C. LaMattina et al.
CURRENT OPINION IN OPHTHALMOLOGY (2018)
Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab
Rabia Miray Kisla Ekinci et al.
PEDIATRICS (2018)
Increased IL-1β levels are associated with an imbalance of oxidant/antioxidant status during Behcet's disease
Arezki Chekaoui et al.
EUROPEAN CYTOKINE NETWORK (2018)
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Safety profile of biologic agents for Behcet's disease in a multicenter observational cohort study
Luca Cantarini et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Clinical and genetic association, radiological findings and response to biological therapy in seven children from Qatar with non-bacterial osteomyelitis
Taha Moussa et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases
Genevieve Baujat et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Efficacy and safety profile of anti-interleukin-1 treatment in Behcet's disease: a multicenter retrospective study
Giacomo Emmi et al.
CLINICAL RHEUMATOLOGY (2016)
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
Alexei A. Grom et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell
Thassila N. Pitanga et al.
CYTOKINE (2016)
Canakinumab for Childhood Sight-threatening Refractory Uveitis: A Case Series
Alice Brambilla et al.
JOURNAL OF RHEUMATOLOGY (2016)
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Quan Dong Nguyen et al.
LANCET (2016)
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
Antonio Vitale et al.
FRONTIERS IN PHARMACOLOGY (2016)
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
Linda Rossi-Semerano et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Successful treatment with canakinumab of a paediatric patient with resistant Behcet's disease
Ilaria Pagnini et al.
RHEUMATOLOGY (2015)
Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period
Kenan Barut et al.
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS (2015)
Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes
Carlos D. Rose et al.
RHEUMATOLOGY (2015)
IL-1 Blockade in Autoinflammatory Syndromes
Adriana A. Jesus et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behcet's Disease: A Case Series
Antonio Vitale et al.
DERMATOLOGY (2014)
Hemolysis-induced lethality involves inflammasome activation by heme
Fabianno F. Dutra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Efficacy of anti-IL-1 treatment in Majeed syndrome
Troels Herlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Clinical and Transcriptional Response to the Long-Acting Interleukin-1 Blocker Canakinumab in Blau Syndrome-Related Uveitis
Gabriele Simonini et al.
ARTHRITIS AND RHEUMATISM (2013)
Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease
Serdal Ugurlu et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Macrophage Activation Syndrome in Autoimmune Disease
Sean Deane et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
WRITING NARRATIVE LITERATURE REVIEWS FOR PEER-REVIEWED JOURNALS: SECRETS OF THE TRADE
Bart N. Green et al.
JOURNAL OF CHIROPRACTIC MEDICINE (2006)
Share Paper
